Germline mutations in RUNX1 lacking the C-terminus, which would disrupt the interaction with PTBP1, have been reported in patients with Familial Platelet Disorder with associated Myeloid Malignancies. This evidence concerns the gene RUNX1 and myeloid neoplasm.